Filtered By:
Drug: Insulin
Management: Healthcare Costs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 150 results found since Jan 2013.
Circulating microRNAs associated with non-alcoholic fatty liver disease
Am J Physiol Cell Physiol. 2023 Jan 16. doi: 10.1152/ajpcell.00253.2022. Online ahead of print.ABSTRACTMicroRNAs (miRNAs) are secreted from cells as either protein bound or enclosed in extracellular vesicles. Circulating liver-derived miRNAs are modifiable by weight-loss or insulin-sensitizing treatments, indicating that they could be important biomarkers candidates for diagnosis, monitoring, and prognosis in NAFLD (non-alcoholic liver disease) and NASH (non-alcoholic steatohepatitis). Unfortunately, the non-invasive diagnosis of NASH and fibrosis remains a key challenge, which limits case finding. Current diagnostic guide...
Source: American Journal of Physiology. Cell Physiology - January 16, 2023 Category: Cytology Authors: Amila Iriskic Atic Maja Thiele Alexander Munk Louise Torp Dalgaard Source Type: research
Gestational malnutrition, hyperemesis gravidarum, and Wernicke's encephalopathy: What is missing?
Nutr Clin Pract. 2022 Oct 17. doi: 10.1002/ncp.10913. Online ahead of print.ABSTRACTHyperemesis gravidarum (HG), or the severe nausea and vomiting of pregnancy, is one of the most dreaded complications of gestation, affecting between 1.5% and 3.0% of pregnant women. From the late 1800s to the mid-1980s, the etiology was frequently cited to have psychological and/or-later-perhaps hormonal origins, which have numbered at least 10. Current research has unearthed a genetic basis for HG that implicates growth differentiation factor 15, insulin-like growth factor binding protein 7, and hormone receptors (namely, glial cell line-...
Source: Nutrition in Clinical Practice - October 17, 2022 Category: Nutrition Authors: Miriam Erick Source Type: research
